Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53.4M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
2.32M
-
Shares change
-
+2.29M
-
Total reported value, excl. options
-
$21.4M
-
Value change
-
+$21.1M
-
Put/Call ratio
-
0.35
-
Number of buys
-
43
-
Price
-
$9.20
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) as of Q1 2021
55 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share as of Q1 2021.
ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.32M shares
of 53.4M outstanding shares and own 4.35% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (818K shares), MILLENNIUM MANAGEMENT LLC (213K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (197K shares), GEODE CAPITAL MANAGEMENT, LLC (178K shares), JANE STREET GROUP, LLC (160K shares), CITADEL ADVISORS LLC (157K shares), Tower Research Capital LLC (TRC) (65K shares), BlackRock Inc. (58.9K shares), Arete Wealth Advisors, LLC (52.8K shares), and Virtu Financial LLC (38.2K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.